Nrg-Bn003- Phase III Trial Of Observation Versus Irradiation For A Gross Totally Resected Grade II Meningioma
Posted Date: May 15, 2019
- Investigator: Kyle Wang
- Specialties: Cancer, Oncology
- Type of Study: Observational/Survey
The goal of this study is to determine the extent of clinical benefit of the addition of adjuvant radiotherapy (RT) to gross total resection (GTR) for patients with newly diagnosed World Health Organization (WHO) grade II meningioma.
Criteria:
To Be Eligible: Diagnosed Grade Ii Meningioma, Age 18 Or Older, No Prior Malignancy In Last 3 Years
Keywords:
Brain Cancer, Cancer, Meningioma, Nrg-Bn003, Phase Iii
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com